Impact of hepatitis B virus basic core promoter mutations on T cell response to an immunodominant HBx-derived epitope

Hepatology

Volumn 45, Issue 5, 2007, Pages 1199-1209

  Malmassari, Silvina Laura ^a,b   Deng, Qiang ^a,b   Fontaine, Hélène ^c   Houitte, Dianne ^d   Rimlinger, François ^a,b   Thiers, Valérie ^a,b   Maillere, Bernard ^d   Pol, Stanislas ^c   Michel, Marie Louise ^a,b  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c université Paris Cité   (France)

^d DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B VIRUS X PROTEIN; HLA DR ANTIGEN; INTERLEUKIN 10; SYNTHETIC PEPTIDE; VIRUS DNA;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENOME ANALYSIS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

DNA, VIRAL; EPITOPES, T-LYMPHOCYTE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES; VIRAL REGULATORY PROTEINS;

EID: 34248653787     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21594     Document Type: Article

References (45)

1. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995;13:29-60.
2. Ganem D, Prince AM. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004;350:1118-1129.
3. Bouchard MJ, Schneider RJ. The enigmatic X gene of hepatitis B virus. J Virol 2004;78:12725-12734.
4. Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001;36:651-660.
5. Baptista M, Kramvis A, Kew MC. High prevalence of 1762(T) 1764(A) mutations in the basic core promorer of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. HEPATOLOGY 1999;29:946-953.
6. Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Franco D, et al. Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancet 1999;80:497-505.
7. Kuang SY, Jackson PE, Wang JB, Lu PX, Munoz A, Qian GS, et al. Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A 2004;101:3575-3580.
8. Leon B, Taylor L, Vargas M, Luftig RB, Albertazzi F, Herrero L, et al. HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers. Virol J 2005;2:60.
9. Iavarone M, Trabut JB, Delpuech O, Carnot F, Colombo M, Kremsdorf D, et al. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using laser capture microdissection. J Hepatol 2003;39:253-261.
10. Stuyver L, De Gendt S, Cadranel JF, Van Geyt C, Van Reybroeck G, Dorent R, et al. Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virus. HEPATOLOGY 1999;29:1876-1883.
11. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C. Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 1999;18:4848-4859.
12. Bertoni R, Sidney J, Fowler P, Chesnut RW, Chisari FV, Sette A. Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 1997;100:503-513.
13. Chisari FV. Cytotoxic T cells and vital hepatitis. J Clin Invest 1997:99: 1472-1477.
14. Maini MK, Boni C, Ogg GS, King AS, Reignat S, Lee CK, et al. Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology 1999;117:1386-1396.
15. Rehermann B, Fowler P, Sidney J, Person J, Redeker A, Brown M, et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 1995; 181:1047-1058.
16. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-229.
17. Bertoletti A, Maini MK. Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection? Curr Opin Immunol 2000:12:403-408.
18. Chung MK, Yoon H, Min SS, Lee HG, Kim YJ, Lee TG, et al. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen. J Immunother 1999; 22:279-287.
19. Hwang YK, Kim NK, Park JM, Lee K, Han WK, Kim HI, et al. HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in virro and in vivo. Vaccine 2002;20:3770-3777.
20. Jung MC, Stemler M, Weimer T, Spengler U, Dohrmann J, Hoffmann R, et al. Immune response of peripheral blood mononuclear ceils to HBx-antigen of hepatitis B vitus. HEPATOLOGY 1991;13:637-643.
21. Lok AS, Heathcote EJ, Hoofnagle JH. Management of hepatitis B: 2000 - summary of a workshop. Gastroenterology 2001;120:1828-1853.
22. Yuan HJ, Ka-Ho Wong D, Doutreloigne J, Sablon E, Lai CL, et al. Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B. J Infect, Epub ahead of print, available Septembet 21, 2006.
23. Texier C, Pouvelle-Moratille S, Busson M, Charron D, Menez A, Maillere B. Complementarity and redundancy of the binding specificity of HLA-DRBl, -DRB3, -DRB4 and -DRB5 molecules. Eur J Immunol 2001;31: 1837-1846.
24. Texier C, Pouvelle S, Busson M, Herve M, Charron D, Menez A, et al. HLA-DR restricted peptide candidates for bee venom immunorherapy. J Immunol 2000;164:3177-3184.
25. Ferrari C, Bertoletti A, Penna A, Cavalli A, Valli A, Missale G, Pilli M, et al. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 1991;88:214-222.
26. Mancini-Bourgine M, Fontaine H, Scott-Algara D, Pol S, Brechot C, Michel ML. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers. HEPATOLOGY 2004; 40:874-882.
27. Franco A, Guidotti L, Hobbs MV, Pasquetto V, Chisari FV. Pathogenic effector function of CD4-positive T helper 1 cells in hepatitis B virus transgenic mice. J Immunol 1997;159:2001-2008.
28. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 1998;188:2199-2204.
29. Jung MC, Diepolder HM, Spengler U, Wierenga EA, Zachoval R, Hoff mann RM, et al. Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection. J Virol 1995:69:3358-3368.
30. Celis E, Ou D, Otvos L Jr. Recognition of hepatitis B surface antigen by human T lymphocytes: proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J Immunol 1988; 140:1808-1815.
31. Mizukoshi E, Sidney J, Livingston B, Ghany M, Hoofnagle JH, Sette A, et al. Cellular immune responses to the hepatitis B virus polymerase. J Immunol 2004;173:5863-5871.
32. Torre F, Cramp M, Owsianka A, Dornan E, Marsden H, Carman W, et al. Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity. J Med Virol 2004:72:370-376.
33. Tsai SL, Chen PJ, Lai MY, Yang PM, Sung JL, Huang JH, et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 1992;89:87-96.
34. Bocher WO, Herzog-Hauff S, Schlaak J, Meyer zum Buschenfeld KH, Lohr HF. Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. HEPATOLOGY 1999;29:238-244.
35. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003;77:4911-4927.
36. Webster GJ, Reignat S, Brown D, Ogg GS, Jones L, Seneviratne SL, et al. Longitudinal analysis of CD8 + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 2004;78:5707-5719.
37. Boni C, Penna A, Ogg GS, Bertoletti A, Pilli M, Cavallo C, et al. Lamivudine treatment can overcome cytotoxic T-cell hypotesponsiveness in chronic hepatitis B: new perspectives for immune therapy. HEPATOLOGY 2001;33:963-971.
38. Pohl-Koppe A, Balashov KE, Steete AC, Logigian EL, Hafler DA. Identification of a T cell subset capable of both IFN-gamma and IL-10 secretion in patients with chronic Borrelia burgdorferi infection. J Immunol 1998; 160:1804-1810.
39. Vingerhoets J, Michielsen P, Vanham G, Bosnians E, Paulij W, Ramon A, et al. HBV-specific lymphoproliferative and cytokine responses in patients with chronic hepatitis B. J Hepatol 1998;28:8-16.
40. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997:389:737-742.
41. Accapezzato D, Francavilla V, Paroli M, Casciaro M, Chircu LV, Cividini A, et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 2004;113: 963-972.
42. Bauer T, Weinberger K, JiIg W. Variants of two major T cell epitopes within the hepatitis B surface antigen are not recognized by specific T helper cells of vaccinated individuals. HEPATOLOGY 2002;35: 455-465.
43. Yuen MF, Sablon E, Yuan HJ, Hui CK, Wong DK, Doutreloigne J, et al. Relationship between the development of precore and core promotet mutations and hepatitis B e antigen seroconversion in patients with chronic hepatitis B virus. J Infect Dis 2002;186:1335-1338.
44. Yim HJ, Lok AS. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. HEPATOLOGY 2006; 43:S173-181.
45. Fukuda R, Nguyen XT, Ishimura N, Ishihara S, Chowdhury A, Kohge N, et al. X gene and precore region mutations in the hepatitis B virus genome in persons positive for antibody to hepatitis B e antigen: comparison between asymptomatic "healthy" carriers and patients with severe chronic active hepatitis. J Infect Dis 1995:172:1191-1197.